Putative tumor suppressor miR-145 inhibits colon cancer cell growth by targeting oncogene friend leukemia virus integration 1 gene

Authors

  • Jianjun Zhang MD, PhD,

    1. Department of Biochemistry and Molecular Biology, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China
    2. Ninth People's Hospital, Shanghai Jiaotong University School of Medicine Shanghai, People's Republic of China
    Search for more papers by this author
    • The first 2 authors contributed equally to this article.

  • Haiyan Guo MD,

    1. Department of Biochemistry and Molecular Biology, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China
    Search for more papers by this author
    • The first 2 authors contributed equally to this article.

  • He Zhang PhD,

    1. Department of Biochemistry and Molecular Biology, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China
    2. VA Palo Alto Health Care System, Stanford University Medical School, Palo Alto, California
    Search for more papers by this author
  • Haibo Wang MD, PhD,

    1. Department of Biochemistry and Molecular Biology, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China
    2. VA Palo Alto Health Care System, Stanford University Medical School, Palo Alto, California
    Search for more papers by this author
  • Guanxiang Qian MD,

    1. Department of Biochemistry and Molecular Biology, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China
    Search for more papers by this author
  • Xianqun Fan MD, PhD,

    1. Ninth People's Hospital, Shanghai Jiaotong University School of Medicine Shanghai, People's Republic of China
    Search for more papers by this author
  • Andrew R. Hoffman MD,

    1. VA Palo Alto Health Care System, Stanford University Medical School, Palo Alto, California
    Search for more papers by this author
  • Ji-Fan Hu,

    Corresponding author
    1. VA Palo Alto Health Care System, Stanford University Medical School, Palo Alto, California
    • Department of Medicine, VA Palo Alto Health Care System, Palo Alto, CA 94304
    Search for more papers by this author
    • Fax: (650) 856-8024

  • Shengfang Ge PhD

    Corresponding author
    1. Department of Biochemistry and Molecular Biology, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China
    2. Ninth People's Hospital, Shanghai Jiaotong University School of Medicine Shanghai, People's Republic of China
    • Shanghai Jiao Tong University School of Medicine, Shanghai 200025, P.R. China
    Search for more papers by this author

Abstract

BACKGROUND:

Tumor suppressor microRNA miR-145 is commonly down-regulated in colon carcinoma tissues, but its specific role in tumors remains unknown.

METHODS:

In this study, the authors identified the Friend leukemia virus integration 1 gene (FLI1) as a novel target of miR-145. FLI1 is involved in t(11;22)(q24:q12) reciprocal chromosomal translocation in Ewing sarcoma, and its expression appears to be associated with biologically more aggressive tumors.

RESULTS:

The authors demonstrated that miR-145 targets a putative microRNA regulatory element in the 3′-untranslated region (UTR) of FLI1, and its abundance is reversely associated with FLI1 expression in colon cancer tissues and cell lines. By using a luciferase/FLI1 3′-UTR reporter system, they found that miR-145 down-regulated the reporter activity, and this down-regulation was reversed by anti–miR-145. Mutation of the miR-145 microRNA regulatory element sequence in the FLI1 3′-UTR abolished the activity of miR-145. miR-145 decreased FLI1 protein but not FLI1 mRNA, suggesting a mechanism of translational regulation. Furthermore, the authors demonstrated that miR-145 inhibited cell proliferation and sensitized LS174T cells to 5-fluorouracil–induced apoptosis.

CONCLUSIONS:

Taken together, these results suggest that miR-145 functions as a tumor suppressor by down-regulating oncogenic FLI1 in colon cancer. Cancer 2011. © 2010 American Cancer Society.

Ancillary